MedTrace Logo

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

NCT02509975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-08-08

No results posted yet for this study

Summary

This is a prospective, pilot, open-label, uncontrolled, non-randomized safety and effectiveness study of OCL 503 in men with BPH.

Conditions

  • Benign Prostatic Hyperplasia
  • Benign Prostatic Hypertrophy

Interventions

DEVICE

Prostate artery embolization.

Embolization of the prostatic vasculature with OCL 503 using a microcatheter.

Sponsors & Collaborators

  • IMBiotechnologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Richard Owen, MD · University of Alberta

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
51 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02509975 on ClinicalTrials.gov